Neolight is a medical device company that develops phototherapy beds to cure jaundice in pre-term and full term babies.
NeoLight has raised $2.8M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in January 2022.
NeoLight's investors include Revolution, Revolution’s Rise of the Rest Seed Fund, HonorHealth, Dignity Health, Ashley Roethlisberger.
NeoLight is headquartered in Scottsdale, United States.
Neolight is a medical device company that develops phototherapy beds to cure jaundice in pre-term and full term babies.
NeoLight is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"NeoLight — Funding & Investors." VCBacked, January 13, 2022, https://www.vcbacked.co/company/neolight. Accessed August 17, 2026.
VCBacked. (2022). NeoLight — Funding & Investors. Retrieved August 17, 2026, from https://www.vcbacked.co/company/neolight
{{cite web |title=NeoLight — Funding & Investors |url=https://www.vcbacked.co/company/neolight |website=VCBacked |access-date=August 17, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated